Table 3. Levels of hemoglobin (Hb), haptoglobin (Hp) and hemopexin (Hx) associated with HDL in 32 sickle cell disease (SCD) patients and 28 healthy normal donors (Control).
A | |||
ELISA (Relative concentration) | Control(Mean ± SD) | SCD(Mean ± SD) | p* |
Hemoglobin | 1.00±0.43 | 3.74±0.31 | < 0.001 |
Haptoglobin | 1.00±0.45 | 1.87±0.68 | < 0.001 |
Hemopexin | 1.00±0.34 | 1.54±0.52 | < 0.001 |
ApoA-1 | 1.00±0.49 | 0.72±0.26 | < 0.05 |
B | |||
HDL-captured ELISA | Control(Mean ± SD) | SCD(Mean ± SD) | p* |
(Relative concentration) | |||
Hemoglobin | 1.00±0.35 | 2.58±1.24 | < 0.0001 |
Haptoglobin | 1.00±0.32 | 2.14±0.79 | < 0.0001 |
Hemopexin | 1.00±0.41 | 1.41±0.51 | < 0.05 |
ApoA-1 | 1.00±0.32 | 0.78±0.42 | <0.05 |
C | |||
ApoA-1-captured ELISA | Control(Mean ± SD) | SCD(Mean ± SD) | p* |
(Relative concentration) | |||
Hemoglobin | 1.00±0.43 | 3.02±1.68 | < 0.0001 |
Haptoglobin | 1.00±0.38 | 2.31±0.97 | < 0.0001 |
Hemopexin | 1.00±0.21 | 1.53±0.38 | < 0.01 |
ApoA-1 | 1.00±0.27 | 0.97±0.30 | NS |
ELISA, enzyme-linked immunosorbent assay; SD, standard deviation.
*analyzed by a t-test.